person
Melker H.
- Country
- Sweden
- Department
- Kungälvs sjukhus, ECT-och rTMF Mottagning
Research Overview
assignment
1
Clinical Trials ·
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies
Has run more than one trial at 0 of 7 partner sites.
Specializations
Major Depressive Disorder
The investigation targets Major Depressive Disorder in adult populations.
- Efficacy of novel augmentation strategies
- Symptom severity assessment using standardized scales
- Management of treatment‑resistant depression
Collaboration extends to regional psychiatric centers across Sweden.
Accelerated Intermittent Theta‑Burst Stimulation
Clinical focus includes the application of Accelerated Intermittent Theta‑Burst Stimulation for rapid mood improvement.
- Protocol optimization for intensive delivery
- Investigation of rapid symptom relief dynamics
- Exploration of neuroplasticity modulation effects
Procedures are conducted within a dedicated ECT‑and‑rTMS unit.
Pharmacological Augmentation with D‑Cycloserine
Research evaluates the role of D‑Cycloserine as an adjunct to neurostimulation therapies.
- NMDA‑receptor modulation in depressive pathology
- Adjunctive oral dosing regimens
- Placebo‑controlled efficacy outcomes
Integration of pharmacologic and neuromodulatory approaches aims to enhance therapeutic response.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.